Review



anti mouse b7 h1 pd l1 polyclonal antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    R&D Systems anti mouse b7 h1 pd l1 polyclonal antibody
    Anti Mouse B7 H1 Pd L1 Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 86/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+b7/us12577307-579-18-22?v=R%26D+Systems
    Average 86 stars, based on 3 article reviews
    anti mouse b7 h1 pd l1 polyclonal antibody - by Bioz Stars, 2026-08
    86/100 stars

    Images



    Similar Products

    mouse b7-h1/pd-l1/cd274 elisa kit  (Multi Sciences (Lianke) Biotech Co Ltd)
    91
    Multi Sciences (Lianke) Biotech Co Ltd mouse b7-h1/pd-l1/cd274 elisa kit
    Mouse B7 H1/Pd L1/Cd274 Elisa Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+b7/custom%40ek2261%4041703282?v=Multi+Sciences+%28Lianke%29+Biotech+Co+Ltd
    Average 91 stars, based on 1 article reviews
    mouse b7-h1/pd-l1/cd274 elisa kit - by Bioz Stars, 2026-08
    91/100 stars
    		  Buy from Supplier
    mouse pd-l1/b7-h1 antibody  (Bio-Techne corporation)
    99
    Bio-Techne corporation mouse pd-l1/b7-h1 antibody
    Mouse Pd L1/B7 H1 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+b7/custom%40af1019%4042207634?v=Bio-Techne+corporation
    Average 99 stars, based on 1 article reviews
    mouse pd-l1/b7-h1 antibody - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    mouse  (MedChemExpress)
    92
    MedChemExpress mouse
    Mouse, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+b7/pmc13099120-71-13-14?v=MedChemExpress
    Average 92 stars, based on 1 article reviews
    mouse - by Bioz Stars, 2026-08
    92/100 stars
    		  Buy from Supplier
    biotinylated recombinant mouse b7h3  (Sino Biological)
    94
    Sino Biological biotinylated recombinant mouse b7h3
    Biotinylated Recombinant Mouse B7h3, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+b7/pm41826511-853-14-18?v=Sino+Biological
    Average 94 stars, based on 1 article reviews
    biotinylated recombinant mouse b7h3 - by Bioz Stars, 2026-08
    94/100 stars
    		  Buy from Supplier
    monkey  (MedChemExpress)
    92
    MedChemExpress monkey
    Monkey, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+b7/pmc13099120-71-9-10?v=MedChemExpress
    Average 92 stars, based on 1 article reviews
    monkey - by Bioz Stars, 2026-08
    92/100 stars
    		  Buy from Supplier
    invivomab anti mouse pd l1 b7 h1 antibody  (Bio X Cell)
    96
    Bio X Cell invivomab anti mouse pd l1 b7 h1 antibody
    Evaluation of in vivo tumor growth inhibition by PBSN38-CUR. (A) Schematic illustration of the therapeutic schedule in a 4T1 murine breast cancer model. (B) Tumor volume change curves of the mice following various treatments. The 4T1 tumors harvested after the therapeutic evaluation were photographed and weighed (C and D) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). Tumor-bearing mice were intravenously injected with PBSN38-CUR at an SN38-equivalent dose of 4 mg kg −1 and then treated without or with US irradiation (3 MHz, 1.5 W cm −2 , 50 % duty cycle, 10 min) 4 h after intravenous injection. (E) Representative images of H&E and TUNEL staining in 4T1 tumor sections after different treatments. Scale bar: 100 μm. (F) Characterization of tumoral DC maturation and CD8 + and Foxp3 + T cell infiltration following various treatments. (G) Serum inflammatory cytokine secretion from mice after various treatments. (H) H&E staining of lung tissue collected from mice 15 days after various treatments. (I) Tumor volume change curves of the mice after PBSN38-CUR and <t>anti-PD-L1</t> antibody combination treatments. The 4T1 tumors harvested at the end of the therapeutic evaluation were photographed and weighed (J and K) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). One-way analysis of variance (ANOVA) followed by the post-Tukey's multiple comparisons test was used to compare multiple groups.
    Invivomab Anti Mouse Pd L1 B7 H1 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+b7/pmc12907047-52-12-20?v=Bio+X+Cell
    Average 96 stars, based on 1 article reviews
    invivomab anti mouse pd l1 b7 h1 antibody - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    invivoplus anti mouse pd l1 b7 h1 monoclonal antibody  (Bio X Cell)
    96
    Bio X Cell invivoplus anti mouse pd l1 b7 h1 monoclonal antibody
    Evaluation of in vivo tumor growth inhibition by PBSN38-CUR. (A) Schematic illustration of the therapeutic schedule in a 4T1 murine breast cancer model. (B) Tumor volume change curves of the mice following various treatments. The 4T1 tumors harvested after the therapeutic evaluation were photographed and weighed (C and D) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). Tumor-bearing mice were intravenously injected with PBSN38-CUR at an SN38-equivalent dose of 4 mg kg −1 and then treated without or with US irradiation (3 MHz, 1.5 W cm −2 , 50 % duty cycle, 10 min) 4 h after intravenous injection. (E) Representative images of H&E and TUNEL staining in 4T1 tumor sections after different treatments. Scale bar: 100 μm. (F) Characterization of tumoral DC maturation and CD8 + and Foxp3 + T cell infiltration following various treatments. (G) Serum inflammatory cytokine secretion from mice after various treatments. (H) H&E staining of lung tissue collected from mice 15 days after various treatments. (I) Tumor volume change curves of the mice after PBSN38-CUR and <t>anti-PD-L1</t> antibody combination treatments. The 4T1 tumors harvested at the end of the therapeutic evaluation were photographed and weighed (J and K) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). One-way analysis of variance (ANOVA) followed by the post-Tukey's multiple comparisons test was used to compare multiple groups.
    Invivoplus Anti Mouse Pd L1 B7 H1 Monoclonal Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+b7/pm41863725-30-1-14?v=Bio+X+Cell
    Average 96 stars, based on 1 article reviews
    invivoplus anti mouse pd l1 b7 h1 monoclonal antibody - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    anti mouse b7 h1 pd l1 polyclonal antibody  (R&D Systems)
    86
    R&D Systems anti mouse b7 h1 pd l1 polyclonal antibody
    Evaluation of in vivo tumor growth inhibition by PBSN38-CUR. (A) Schematic illustration of the therapeutic schedule in a 4T1 murine breast cancer model. (B) Tumor volume change curves of the mice following various treatments. The 4T1 tumors harvested after the therapeutic evaluation were photographed and weighed (C and D) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). Tumor-bearing mice were intravenously injected with PBSN38-CUR at an SN38-equivalent dose of 4 mg kg −1 and then treated without or with US irradiation (3 MHz, 1.5 W cm −2 , 50 % duty cycle, 10 min) 4 h after intravenous injection. (E) Representative images of H&E and TUNEL staining in 4T1 tumor sections after different treatments. Scale bar: 100 μm. (F) Characterization of tumoral DC maturation and CD8 + and Foxp3 + T cell infiltration following various treatments. (G) Serum inflammatory cytokine secretion from mice after various treatments. (H) H&E staining of lung tissue collected from mice 15 days after various treatments. (I) Tumor volume change curves of the mice after PBSN38-CUR and <t>anti-PD-L1</t> antibody combination treatments. The 4T1 tumors harvested at the end of the therapeutic evaluation were photographed and weighed (J and K) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). One-way analysis of variance (ANOVA) followed by the post-Tukey's multiple comparisons test was used to compare multiple groups.
    Anti Mouse B7 H1 Pd L1 Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+b7/us12577307-579-18-22?v=R%26D+Systems
    Average 86 stars, based on 1 article reviews
    anti mouse b7 h1 pd l1 polyclonal antibody - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    recombinant mouse b7h3 protein  (MedChemExpress)
    92
    MedChemExpress recombinant mouse b7h3 protein
    Evaluation of in vivo tumor growth inhibition by PBSN38-CUR. (A) Schematic illustration of the therapeutic schedule in a 4T1 murine breast cancer model. (B) Tumor volume change curves of the mice following various treatments. The 4T1 tumors harvested after the therapeutic evaluation were photographed and weighed (C and D) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). Tumor-bearing mice were intravenously injected with PBSN38-CUR at an SN38-equivalent dose of 4 mg kg −1 and then treated without or with US irradiation (3 MHz, 1.5 W cm −2 , 50 % duty cycle, 10 min) 4 h after intravenous injection. (E) Representative images of H&E and TUNEL staining in 4T1 tumor sections after different treatments. Scale bar: 100 μm. (F) Characterization of tumoral DC maturation and CD8 + and Foxp3 + T cell infiltration following various treatments. (G) Serum inflammatory cytokine secretion from mice after various treatments. (H) H&E staining of lung tissue collected from mice 15 days after various treatments. (I) Tumor volume change curves of the mice after PBSN38-CUR and <t>anti-PD-L1</t> antibody combination treatments. The 4T1 tumors harvested at the end of the therapeutic evaluation were photographed and weighed (J and K) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). One-way analysis of variance (ANOVA) followed by the post-Tukey's multiple comparisons test was used to compare multiple groups.
    Recombinant Mouse B7h3 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+b7/pm41826511-901-0-4?v=MedChemExpress
    Average 92 stars, based on 1 article reviews
    recombinant mouse b7h3 protein - by Bioz Stars, 2026-08
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    Evaluation of in vivo tumor growth inhibition by PBSN38-CUR. (A) Schematic illustration of the therapeutic schedule in a 4T1 murine breast cancer model. (B) Tumor volume change curves of the mice following various treatments. The 4T1 tumors harvested after the therapeutic evaluation were photographed and weighed (C and D) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). Tumor-bearing mice were intravenously injected with PBSN38-CUR at an SN38-equivalent dose of 4 mg kg −1 and then treated without or with US irradiation (3 MHz, 1.5 W cm −2 , 50 % duty cycle, 10 min) 4 h after intravenous injection. (E) Representative images of H&E and TUNEL staining in 4T1 tumor sections after different treatments. Scale bar: 100 μm. (F) Characterization of tumoral DC maturation and CD8 + and Foxp3 + T cell infiltration following various treatments. (G) Serum inflammatory cytokine secretion from mice after various treatments. (H) H&E staining of lung tissue collected from mice 15 days after various treatments. (I) Tumor volume change curves of the mice after PBSN38-CUR and anti-PD-L1 antibody combination treatments. The 4T1 tumors harvested at the end of the therapeutic evaluation were photographed and weighed (J and K) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). One-way analysis of variance (ANOVA) followed by the post-Tukey's multiple comparisons test was used to compare multiple groups.

    Journal: Materials Today Bio

    Article Title: Ultrasound-triggered carrier-free nanoprodrugs activate cGAS-STING pathway to enhance tumor-targeting chemo-immunotherapy

    doi: 10.1016/j.mtbio.2026.102858

    Figure Lengend Snippet: Evaluation of in vivo tumor growth inhibition by PBSN38-CUR. (A) Schematic illustration of the therapeutic schedule in a 4T1 murine breast cancer model. (B) Tumor volume change curves of the mice following various treatments. The 4T1 tumors harvested after the therapeutic evaluation were photographed and weighed (C and D) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). Tumor-bearing mice were intravenously injected with PBSN38-CUR at an SN38-equivalent dose of 4 mg kg −1 and then treated without or with US irradiation (3 MHz, 1.5 W cm −2 , 50 % duty cycle, 10 min) 4 h after intravenous injection. (E) Representative images of H&E and TUNEL staining in 4T1 tumor sections after different treatments. Scale bar: 100 μm. (F) Characterization of tumoral DC maturation and CD8 + and Foxp3 + T cell infiltration following various treatments. (G) Serum inflammatory cytokine secretion from mice after various treatments. (H) H&E staining of lung tissue collected from mice 15 days after various treatments. (I) Tumor volume change curves of the mice after PBSN38-CUR and anti-PD-L1 antibody combination treatments. The 4T1 tumors harvested at the end of the therapeutic evaluation were photographed and weighed (J and K) . Scale bar: 20 mm. Data were expressed as mean ± standard deviation of biological replicates (n = 5). One-way analysis of variance (ANOVA) followed by the post-Tukey's multiple comparisons test was used to compare multiple groups.

    Article Snippet: Picogreen dsDNA quantitation reagent was purchased from Yeasen Biotechnology (Shanghai) Co., Ltd. InVivoMAb anti-mouse PD-L1 (B7-H1) antibody was purchased from Bioxcell.

    Techniques: In Vivo, Inhibition, Standard Deviation, Injection, Irradiation, TUNEL Assay, Staining